Smoking Cessation Drug Varenicline Helps Young Adults Quit Vaping
Congratulations to Dr. Eden Evins, Dr. Randi Schuster, and CAM staff who recently published a study which showed that teens and young adults who took Varenicline—an FDA-approved, twice-daily smoking cessation pill for adults—are more than three times as likely to successfully quit vaping compared to those who received only behavioral counseling. See further details published by the Mass General Brigham Newsroom here.
You can find the published paper on the JAMA network website here.